Health
Chronicle Pharmabiz
AI propels shift in Indian lifesciences industry
INDIAN lifesciences industry sees that artificial intelligence (AI) is propelling the transformative shift with scalable, data-driven solutions that are already demonstrating real-world impact.
1 min |
July 24, 2025
Chronicle Pharmabiz
Pkg systems should show container - closure integrity
There are a number of water vapour transmission rate/moisture vapour transmission rate testing methods that conform to be recognized United States and international ASTM, ISO, and TAPPI standards such as Gravimetric (Cup) method; Electrolytic detection sensor method; Infrared detection sensor method; Humidity detection sensor method.
1 min |
July 24, 2025
Chronicle Pharmabiz
IISC, Tufts Univ to combat malnutrition, metabolic health research
THE Indian Institute of Science (IISc) and Tufts University (Massachusetts, US)'s global nutrition research centre will propel research on malnutrition and obesity. Here IISc's engineering and tech strengths, combined with Tufts' nutrition science, will fuel innovation in sensor development, tele-nutrition tools, and Al-driven analytics.
2 min |
July 24, 2025
Chronicle Pharmabiz
US FDA accepts BMS's sNDA of Sotyktu for review
BRISTOL Myers Squibb (BMS) announced that the US FDA has accepted for review the supplemental New Drug Application (sNDA) for Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
1 min |
July 24, 2025
Chronicle Pharmabiz
CDSCO issues SEC norms elaborating application, recommendation processes
THE CDSCO has released the Subject Expert Committees (SECs) guidance document, elaborating the role of SEC and its members, the step-by-step process involved in the SECs review and recommendation processes, and the roles and responsibilities of the applicant stakeholder in the evaluation process, among others.
1 min |
July 24, 2025
Chronicle Pharmabiz
'Genomic profiling is shaping personalized cancer treatments'
GENOMIC profiling is now central to therapeutic decision-making in oncology. The clinical management of cancer is undergoing a fundamental shift from organ-based treatment algorithms to biomarker-driven precision strategies. At the heart of this transition is genomic profiling, which is increasingly central to therapeutic decision-making in oncology, said Dr Vamsi Veeramachaneni, chief scientific officer, Strand Life Sciences.
1 min |
July 24, 2025
Chronicle Pharmabiz
Microbial contamination limits to be amended
THE drug regulators are working towards addressing a mismatch between the recommended limit of microbial contamination stipulated in the Schedule M of the D&C Act, 1940, for the highest cleanroom classification, with the limits advised under the WHO Technical Report Series (TRS).
1 min |
July 24, 2025
Chronicle Pharmabiz
Pharma cos shift from digitization to tech innovation
INDIAN pharmaceutical companies, particularly the big players with a global footprint, are evolving rapidly.
1 min |
July 24, 2025
Chronicle Pharmabiz
Sustainable packaging in regulated industries
SUSTAINABILITY is no longer a side conversation in the pharmaceutical and healthcare industries; it’s very much in focus. With global attention on climate change, supply chain emissions, and plastic waste, companies are being held accountable not just for what they produce, but also for how they package it. And in a sector where product safety, stability, and compliance are paramount, that’s a tricky balancing act.
3 min |
July 24, 2025
Chronicle Pharmabiz
CDSCO revises document on export NOC for unapproved FDCs
THE Central Drugs Standard Control Organisation (CDSCO) has revised the guidance document for issuance of No Objection Certificate (NOC) for manufacture of unapproved or approved new drugs for export purpose to bring in a couple of changes including in the document required for export NOC for unapproved FDCs in India under the finished formulation category.
1 min |
July 24, 2025
Chronicle Pharmabiz
Two to six, where is the fix?
THERE is a debate going on in the circle of highly qualified pharmacists, especially among the pharmacy teachers, that, what should be the minimum duration of pharmacist course. This is intensified after the Pharmacy Council of India announced its decision of splitting B. Pharm course into B. Pharm Industrial and B. Pharm Clinical courses. But there are lot of voices for and few against the proposal. Some even suggesting entirely a new course. Let us discuss the pros and cons of all those views in brief.
5 min |
July 24, 2025
Chronicle Pharmabiz
Indian MedTech focuses on innovation laying foundation for self-reliance
INDIA'S medical technology industry has entered a defining chapter, led by local teams advancing innovation and laying the foundation for long-term self-reliance.
1 min |
July 24, 2025
Chronicle Pharmabiz
'PLI, MedTech Parks to build innovative ecosystem'
THE production linked incentive (PLI) scheme and the establishment of MedTech Parks are significant initiatives by the Union government aimed at fostering a self-reliant and innovation-driven medical technology ecosystem, said Anish Bafna, CEO & MD, Healthium Medtech.
1 min |
July 24, 2025
Chronicle Pharmabiz
Gandhi Automations' high-speed doors minimize air permeability, leakages
GANDHI Automations Pvt Ltd offers prime clean reset high-speed doors for ensuring clean room integrity, minimizing air permeability and leakages.
3 min |
July 24, 2025
Chronicle Pharmabiz
Applications invited for Pharmexcil Awards
THE Pharmaceuticals Export Promotion Council of India (Pharmexcil) has invited applications for the Outstanding Export Performance Awards for the financial year 2023-24. These prestigious awards aim to recognize the exemplary efforts of Indian pharmaceutical exporters contributing significantly to the sector's growth and global recognition.
1 min |
July 24, 2025
Chronicle Pharmabiz
PackPlus redefines business opportunities in packaging
THE packaging technology sector is undergoing significant transformation, driven by changing consumer demands, sustainability pressures, and rapid technological advancements. The packaging industry in India is poised for major growth and transformation like never before, driven by a combination of innovative practices and emerging trends.
5 min |
July 24, 2025
Chronicle Pharmabiz
Merck to buy Verona Pharma for $10 bn
MERCK, known as MSD outside of the United States and Canada, and Verona Pharma plc, a biopharmaceutical company focused on respiratory diseases, announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Verona Pharma for $107 per American Depository Share, each of which represents eight Verona Pharma ordinary shares, for a total transaction value of approximately $10 billion.
1 min |
July 17, 2025
Chronicle Pharmabiz
Thalassemia India, TPAG recognize resilience of patients
THALASSEMICS India in collaboration with the Thalassemia Patients Advocacy Group (TPAG) hosted the 2nd edition of the Santosh & Arjun Dev Taneja Memorial Awards for Excellence 2025.
1 min |
July 17, 2025
Chronicle Pharmabiz
Fischer Medical with City of Jember to support Indonesia's fight against TB
FISCHER Medical Ventures (FMV) has inked a public-private initiative in partnership with the City of Jember, Indonesia, supporting the city with multiple portable, AI-enabled digital x-ray systems designed for mobility, low-radiation exposure, and rapid diagnostics to help 'Free Tuberculosis (TB) in Jember' by 2026.
1 min |
July 17, 2025
Chronicle Pharmabiz
Pharmexcil flags export risk from COPP mandate
THE Pharmaceuticals Export Promotion Council of India (Pharmexcil) has expressed concern over the recent circular issued by the Central Drugs Standard Control Organization (CDSCO), which mandates exclusive online submission of Certificate of Pharmaceutical Product (COPP) applications via the Online National Drugs licensing system (ONDLS) portal.
1 min |
July 17, 2025
Chronicle Pharmabiz
Gene therapy, rapid test seen as a new hope for SCD: Experts
HIGH-tech gene therapy with affordable diagnostic tools is seen to be a groundbreaking leap for sickle cell disease (SCD) care in India.
2 min |
July 17, 2025
Chronicle Pharmabiz
Lupin Diagnostics achieves NABL certification for all greenfield labs
LUPIN Diagnostics, a wholly owned subsidiary of global pharma major Lupin Limited (Lupin), has achieved 100 per cent NABL (National Accreditation Board for Testing and Calibration Laboratories) accreditation across all its greenfield labs.
1 min |
July 17, 2025
Chronicle Pharmabiz
Investors invited to transform India's API landscape
A high-level government delegation led by the R D Nazeem, Additional Chief Secretary (Industries), Himachal Pradesh (HP), is embarking on a strategic mission in Mumbai to engage with key stakeholders and investors in the ambitious Himachal Pradesh Bulk Drug Park Infrastructure Ltd. (HPBDPIL) project.
1 min |
July 17, 2025
Chronicle Pharmabiz
Industry concerned over moisture menace altering colour, taste of medicines
THE Indian pharmaceutical industry is now concerned over the moisture menace which alters the colour, smell, and taste of medicines.
2 min |
July 17, 2025
Chronicle Pharmabiz
Pharmexcil, USP discuss collaboration on biosimilar accessibility
THE Pharmaceuticals Export Promotion Council of India (Pharmexcil) has discussed synergies with the United States Pharmacopoeia (USP) to ensure access to biosimilars particularly in lowand middle-income countries, identify high-risk APIs prone to shortages and global best practices as part of the USP resolutions for 2025-2030.
2 min |
July 17, 2025
Chronicle Pharmabiz
HC asks CCSEA to inspect Palamur Bio
THE Delhi High Court (HC) has asked the Committee for Control and Supervision of Experiments on Animals (CCSEA) to conduct an inspection along with the representatives of the People for the Ethical Treatment of Animals India (PETA India) and submit a status report within four weeks regarding the animal experiments and related issues in Telangana-based Palamur Biosciences.
2 min |
July 17, 2025
Chronicle Pharmabiz
DGTR initiates investigation on MAA from China
THE Directorate General of Trade Remedies (DGTR), under the ministry of commerce and industry, Government of India, has initiated sunset review investigation concerning the anti-dumping duty on methyl acetoacetate (MAA) imported from China.
1 min |
July 17, 2025
Chronicle Pharmabiz
Indian pharma powers ahead with research on NDDS
INDIAN Pharma is undergoing a significant transformation, not just in discovering novel therapeutics, but in its mode of innovative drug delivery.
2 min |
July 17, 2025
Chronicle Pharmabiz
Omron, Tricog launch KeeboHealth for cardiac care
OMRON Healthcare, a global leader in innovative home health monitoring solutions, has expanded its collaboration with Tricog Health, an Al-driven cardiac care company, to launch KeeboHealth, an advanced connected health platform designed to transform remote cardiac care and accelerate progress toward Omron's ambitious 'Going for Zero' vision, a world with zero cardiovascular events.
1 min |
July 17, 2025
Chronicle Pharmabiz
'Small pharma cos struggle with revised Schedule M compliance'
SMALL pharma companies are unprepared for the revised Schedule M even as the deadline for its implementation December 31, 2025 looms large.
1 min |